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Dopamine and sleep have been independently linked with hippocampus-dependent learning.
Since D2 dopaminergic transmission is required for the occurrence of rapid-eye-movement (REM)
sleep, it is possible that dopamine affects learning by way of changes in post-acquisition REM
sleep. To investigate this hypothesis, we ﬁrst assessed whether D2 dopaminergic modulation in
mice affects novel object preference, a hippocampus-dependent task. Animals trained in the
dark period, when sleep is reduced, did not improve signiﬁcantly in performance when tested
24 h after training. In contrast, animals trained in the sleep-rich light period showed signiﬁcant
learning after 24 h. When injected with the D2 inverse agonist haloperidol immediately after the
exploration of novel objects, animals trained in the light period showed reduced novelty
preference upon retesting 24 h later. Next we investigated whether haloperidol affected the
protein levels of plasticity factors shown to be up-regulated in an experience-dependent manner
during REM sleep. Haloperidol decreased post-exploration hippocampal protein levels at 3 h, 6 h
and 12 h for phosphorylated Ca2+/calmodulin-dependent protein kinase II, at 6 h for Zif-268; and
at 12 h for the brain-derived neurotrophic factor. Electrophysiological and kinematic recordings
showed a signiﬁcant decrease in the amount of REM sleep following haloperidol injection, while
slow-wave sleep remained unaltered. Importantly, REM sleep decrease across animals was
strongly correlated with deﬁcits in novelty preference (Rho=0.56, p=0.012). Altogether, theo.2015.01.011
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equally to this work.
A.S.C. França et al.494results suggest that the dopaminergic regulation of REM sleep affects learning by modulating
post-training levels of calcium-dependent plasticity factors.
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The neurotransmitter dopamine is involved with the acquisi-
tion of hippocampal-dependent memories (Rossato et al.,
2009). While most studies have focused on D1/D5 receptors
(Lisman and Grace, 2005; Lemon and Manahan-Vaughan, 2006;
Rossato et al., 2009), a role for D2 receptors in hippocampus-
dependent memory acquisition and/or consolidation has been
proposed (Manahan-Vaughan and Kulla, 2003; De Lima et al.,
2011). D2 receptors are also known to control the sleep–wake
cycle (Dzirasa et al., 2006; Monti and Monti, 2007; Lima et al.,
2007, Morice et al., 2007; Lima et al., 2008). Hyperdopami-
nergic mice knockout for the dopamine transporter display
robust REM sleep (Dzirasa et al., 2006), but REM sleep
disappears when animals are treated with alpha-methyl-p-
tyrosine, a dopamine synthesis inhibitor (Dzirasa et al., 2006).
Importantly, a D2 (but not D1) receptor agonist is able to
rescue REM sleep (Dzirasa et al., 2006). These ﬁndings are
consistent with the evidence that blockade of D2 receptors
speciﬁcally decreases REM sleep (Lima et al., 2008). The acute
blockade of D2 receptors by haloperidol is known to impair
learning in the novel object preference test in rats (Proença
et al., 2014) and mice (França et al., 2014). Could the effects
of dopamine on learning be mediated by REM sleep?
Hippocampus-dependent learning increases the duration
and number of REM sleep episodes (Binder et al., 2012).
Several studies have reported the up-regulation of calcium-
dependent plasticity factors during post-acquisition REM sleep
(Ribeiro et al., 1999, 2002, 2007; Ulloor and Datta, 2005), in
line with evidence that sleep deprivation impairs cAMP sign-
aling in the hippocampus (Vecsey et al., 2009). Neural pla-
sticity related to learning is associated with both molecular
and electrophysiological events that lead to gradual changes
in synaptic strength and morphology (Kandel et al., 2014;
Whitlock et al., 2006). Key molecular events include the
phosphorylation of Ca2+/calmodulin-dependent protein
kinase II (CaMKII) (Lisman et al., 2002), and up-regulation of
the protein levels of immediate-early gene Zif-268 (Guzowski,
2002) and brain-derived neurotrophic factor (BDNF) (Panja and
Bramham, 2014). The early increase in pCaMKII levels imme-
diately after memory acquisition is followed by a rise of Zif-
268 protein levels after 1–2 h, and then increased BDNF levels
after 12 h (Bekinschtein et al., 2007; Medina et al., 2008).
These events are necessary for the consolidation of long-las-
ting memories (Bozon et al., 2003; Xia and Storm, 2005), and
for the long-term potentiation (LTP) of electrophysiological
responses implicated as the cellular basis of learning and
memory (Jones et al., 2001; Whitlock et al., 2006).
To gain insight into the relation of dopamine, sleep and
learning, we set out to investigate whether the D2 regulat-
ion of REM sleep correlates with changes in the consolidat-
ion of the object recognition task, a hippocampus-depend-
ent task (Piterkin et al., 2008). To this end, we assessed
electrophysiological and behavioral alterations induced by
haloperidol in mice subjected to the object recognition task.We also investigated how the post-training administration of
haloperidol modulates the hippocampal levels of pCaMKII,
Zif-268 and BDNF. Finally, we combined behavioral, electro-
physiological and kinematic recordings to determine the re-
lationship between learning deﬁcits and haloperidol-induced
changes in sleep. The results suggest that D2 dopaminergic
transmission affects learning by way of changes in REM sleep
and calcium-dependent plasticity factors.
2. Experimental procedures
2.1. Animals
A total of 116 adult male mice were used (C57Bl-6 strain, 2–5 months).
After surgery, animals were housed in cages under a 12 h/12 h light/
dark schedule, with lights on at 07:00, and food and water ad libitum.
Animals were daily handled 10 times for 5 min before the experi-
ments, in order to decrease stress responses. Housing, surgical and
behavioral procedures were in accordance with the guidelines of the
National Institutes of Health, and were approved by the ELS-IINN
Ethics Committee (Protocol number 08/2010).
2.2. Novelty preference task
The task was based on the spontaneous tendency of rodents to
explore novelty (Hughes, 2007). Our task employed 6 different
objects presented over 2 consecutive days; 4 objects were presented
during the initial exploration session (training session, 10 min); and
2 unfamiliar objects replaced 2 familiar objects during the second
exploration session, 24 h later (testing session, 10 min). To evaluate
memory consolidation, an object preference ratio was calculated
(time spent with unfamiliar/familiar objects). Behavioral recordings
began at 10:00 or 22:00 in an open ﬁeld apparatus (50 cm diameter
and 30 cm high). Following object exploration, animals were injected
with haloperidol or vehicle, and were then allowed to behave freely
in their home cages until the second exploration session (Figure 1A).
For animals subjected to electrophysiological recordings, two
training-testing pairs of session were performed within seven days
of each other, the ﬁrst with vehicle and the second with haloperidol.
Locomotion was estimated as the total distance traveled per session.
In behavioral sessions, experiments during the dark period were
conducted under white light.
2.3. Single object exposure and perfusion times for
histochemical analyses
For histochemical analyses, we used mice previously exposed to 10
sessions of handling and a single exposure of 10 min to 4 novel objects,
identical to the training session described above. All experiments in
this case were conducted from 8:00 to 10:00; animals (N=7–10 per
group) received 0.1 ml/10 g injections of haloperidol (0.3 mg/kg) or
vehicle (saline) immediately after object exploration. An additional
group (naïve; N=7) was studied in which the mice were immediately
perfused after being removed from their cages, without object
exploration. With the exception of the naïve group, animals were
returned to their home cages after injection and allowed to
cycle freely through waking (WK) and sleep states for 3 h (n=10
Figure 1 Behavioral task, pharmacology, immunohistochemistry and LFP recordings. (A) Behavioral and pharmacological
procedures. C57BL-6 mice were presented to 4 novel objects at light or dark periods (training session). Haloperidol or vehicle
was injected immediately after exploration (I.A.E.) or 6 h after exploration (6 h A.E.) of novel objects. One day after training,
animals were exposed to 2 novel objects and 2 familiar objects. (B) Immunohistochemistry and histology. At 3, 6 or 12 h after
injection, animals were euthanized, and the brains were processed. Frontal sections were cresyl-stained or subjected to
immunohistochemistry for the transcription factor Zif-268, phosphorylated calcium-calmodulin kinase II (pCaMKII), and brain-
derived neurotrophic factor (BDNF). Labeling quantiﬁcation in hippocampal regions DG, CA3, and CA1 comprised densitometry for
Zif-268, pCaMKII, and BDNF, as well as cell countings for Zif-268, which shows nuclear staining. (C) Local ﬁeld potential recordings
(LFP) were performed in the primary somatosensory (S1) and motor cortices (M1), and in CA1. Inertial recordings from an
accelerometer were also obtained. (D) Spectral maps used to quantitatively sort the major behavioral states of the sleep–wake cycle
(Gervasoni et al., 2004). Top left panel indicates waking (WK, in black), slow wave sleep (SWS, in red), and rapid-eye-movement
sleep (REM, in green); blue denotes state transitions. Top right panel show accelerometer data. High acceleration (hot colors) was
only observed during WK. Bottom left panel shows LFP power in the theta range (6–12 Hz); peak theta power occurs during REM.
Bottom right panel show LFP power in the delta range (1–4.5 Hz); peak delta power occurs during SWS. (E) Placement of the
microelectrode arrays on neuroanatomical diagram overlaid with cresyl-violet stained section. Note electrode tracks in CA1.
495Dopaminergic regulation of learning, sleep and plasticityVH/haloperidol), 6 h (n=7 VH/haloperidol) or 12 h (n=7 VH/haloper-
idol); at the criterion time, animals were deeply anesthetized and
perfused (Figure 1B).2.4. Immunohistochemistry
Animals were anesthetized with isoﬂurane and perfused with
paraformaldehyde 4% in phosphate buffer (PB). The brains were
removed and placed in a solution of 30% sucrose at 4 1C for 24 h.
Subsequently the brains were frozen, frontally sectioned at 30 mm
in a criostat (Zeiss), and thaw-mounted over glass slides. Sections
were incubated as a single batch per plasticity factor in blocking
buffer solution (0.5% fresh skim milk and 0.3% Triton X-100 in 0.1 M
PB) for 30 min, and then incubated overnight at 18 1C in primary
antibody (pCaMKII – 1:200, Millipore; Zif-268–1:100, Santa Cruz
Biotechnology, USA) diluted in blocking buffer. Next, the sections
were washed in PB for 15 min, incubated with a biotinylatedsecondary antibody for 2 h, washed again in PB for 15 min, and
then incubated in avidin–biotin–peroxidase solution (Vector Labs,
USA) for another 2 h. Slides were then placed in a solution
containing 0.03% DAB and 0.001% hydrogen peroxide in 0.1 M PB,
dehydrated and cover-slipped with Entellan (Merck, USA). In order
to conﬁrm labeling speciﬁcity, the primary antibodies were
replaced by blocking buffer in test sections. For BDNF staining,
some changes were made in the protocol. First, we used an
antigenic recovery protocol that consisted in immersing sections
in borate buffer (0.1 M, pH 9.0) and then heating them in a
microwave oven, for two periods of 30 s. Sections were washed in
PB for 15 min. To block endogenous peroxidase, sections were then
incubated for 30 min in 3% H2O2 diluted in 20% methanol. The
sections were then washed in PB for 15 min, incubated in blocking
buffer for 2 h and incubated for 72 h in primary antibody (BDNF –
1:100, Santa Cruz Biotechnology, USA). After this procedure the
steps were the same as described above (Figure 1B).
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Densitometric measurements of pCaMKII, Zif-268 and BDNF staining
were performed with ImageJ software (3 sections/animal, 1.46–
2.06 mm posterior to bregma). Measurements of the corpus callo-
sum were used to subtract staining background values in each
section. Densitometric measurements of the different hippocampal
regions of interest (DG, CA3, CA1) were then normalized by dividing
the mean grey value (in black and white photographs) measured for
each animal by the average of these values from all compared
groups. Unlike pCaMKII and BDNF, which present diffuse cytoplasmic
staining, Zif-268 exhibits nuclear staining. For the cellular quanti-
ﬁcation of Zif-268 staining, labeled nuclei were counted using
Stereo Investigator software (MBF bioscience, USA). In each region
of interest (3 sections/animal, 1.46 mm–2.06 mm posterior to
Bregma), labeled cells were counted within 50 50 μm2 grid
squares. The number of labeled cells per grid (R1) was obtained
for each section. Individual values were then normalized by the
average value of all groups: naïve, VH and haloperidol for each time
point, as well as VH and haloperidol inter-time comparisons
(Figure 1B). Results are presented as the average of the normalized
staining ratio across the three regions of interest (Figure 4), as well
as separated by anatomical region (Supplementary Figure 1).
2.6. Behavioral and kinematic recordings
Behaviors were recorded using a Panasonic camera and AMcap 9.21
free software in behavioral groups. Video recordings were synchro-
nized to local ﬁeld potentials (LFPs) and kinematic data obtained
with a three axis accelerometer sensor (ADXL330, Analog Devices)
tightly installed over the multi-electrode implant.
2.7. Multi-electrode implantation and recordings
For intracranial LFP recordings (Figure 1C), 9 animals were chronically
implanted with 5 electrodes in the hippocampus, 4 electrodes in the
primary motor cortex (M1), and 4 electrodes in the primary somato-
sensory cortex (S1). Each multi-electrode array was 0.9 2.10 mm2
with length 1.5 mm, composed of 50 μm diameter tungsten wires
coated with polyamide, attached to an 18-pin connector (Omnetics
A79040-001). Arrays were implanted under isoﬂurane through an
opening in the skull (Bregma coordinates: 0.55 and 1.65 ML, 0.0 and
2.2 mm AP). An acrylic cap built over the head was secured by
3 screws attached to the skull. One of the screws touched the dura-
mater and was used as recording ground soldered to a silver wire. A 10-
fold pre-ampliﬁcation circuitry was placed 4 cm distant from the
animal's head, in order to reduce noise. LFP signals sampled at a
1000 Hz were pre-ampliﬁed 500 and recorded in a 32-channel system
for neural recording analysis (MAP, Plexon Inc).
2.8. Identiﬁcation of wake–sleep states
LFP, video and kinematic recordings were combined to sort the
different sleep–wake states. Online LFP spectral analysis of the
sleep–wake cycle (Gervasoni et al., 2004; Ribeiro et al., 2007) was
used to identify and quantify occurrence of WK, slow wave-sleep
(SWS) and REM sleep (Figure 1D). Animal behavior and LFPs were
continuously observed and recorded in real time for 12 h. The ﬁrst
4 h of recording were used for comparisons among treatments.
2.9. Haloperidol treatment in behavioral groups
Animals received i.p. injections of haloperidol or vehicle (saline 0.9%).
Haloperidol doses of 0.3 mg/kg i.p. were used, based on previous
studies (Dzirasa et al., 2006; Morice et al., 2007). Depending on theanimal group (Figure 1A), drug or vehicle was applied immediately
after exploration (I.A.E.) or 6 h after exploration (6 h A.E.).
2.10. Haloperidol treatment in electrophysiological
groups
Animals subjected to object exploration received haloperidol
(0.3 mg/kg i.p.) or vehicle I.A.E., deﬁning the Exploration/Halo-
peridol and Exploration/Vehicle groups, respectively. Animals not
subjected to object exploration were injected with haloperidol
(0.3 mg/kg, group Control/Haloperidol) or vehicle (group Control/
Vehicle).
2.11. Histological conﬁrmation of electrode placement
In order to conﬁrm electrode positioning, animals subjected to
multi-electrode implantation were subjected to post-mortem ana-
lysis by Nissl staining. In all cases the electrode tips were located at
the depth of 1.5 mm for cortical electrodes, or in the CA1 layer in
the case of hippocampal electrodes. A representative example is
shown in Figure 1E.
2.12. Statistical analysis
The data were ﬁrst subjected to the Shapiro–Wilk and Kolmogorov–
Smirnov normality tests. The data showed parametric distributions,
and were expressed as mean7the standard error of mean (SEM),
with statistical signiﬁcance set at α=0.05. Two-way ANOVA compar-
isons followed by Bonferroni post-hoc tests were used for behavioral
analyses (period and treatment as independent variables, in
Figure 2A), for immunohistochemical analyses (using time of injec-
tion and treatment as independent variables in Figure 4) and in
electrophysiology groups (with object exposure and treatment as
independent variables in Figure 6A). Bonferroni-corrected one-way
ANOVA followed by Bonferroni post-hoc tests were used for multiple
comparisons among the cell counting groups (Figure 5) and the
staining ratio of separate hippocampal regions (Supplementary
Figure 1). Spearman's correlations were used for verifying the
relation between REM sleep duration and novelty preference ratio
(Figure 6C). The descriptive statistics comprise F, p values and
degrees of freedom (DF) of corresponding one or two-way ANOVAs,
followed by mean7SEM and summary of p values for each post-hoc
test (Table 1, Supplementary Tables 1–4).
3. Results
3.1. Time-dependent effect of haloperidol
injection in the object recognition task
First, we measured the effect of haloperidol on performa-
nce of the object recognition task. A two-way ANOVA (Time
of injection: F (1, 28)=22.24, po0.0001; Treatment: F (1,
28)=11.44, p=0.0021; Interaction: F (1,28)=5.4, p=0.027)
revealed that animals injected with haloperidol and subje-
cted to the task during the dark period showed signiﬁcantly
less object recognition in comparison to animals treated
during the light period (Figure 2A).
Next we compared the effect of haloperidol at two different
time points during the light phase: I.A.E. and 6 h A.E. Figure 2B
shows that the only treatment to impair object recognition
was the administration of haloperidol 0.3 mg/kg I.A.E (two-
way ANOVA: Time of injection: F (1, 28)=2.30, p=0.14, Treat-
ment: F (1, 28)=5.04, p=0.037; Interaction: F (1, 28)=9.5,
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object discrimination within the initial hours after injection.3.2. Haloperidol has a time-dependent effect on
pCaMKII, Zif-268 and BDNF levels
The protein levels of the plasticity factors assessed varied
substantially across naïve, vehicle-treated and haloperidol-
treated animals (Figure 3). 3D illustrates regions of interest
differentially stained for pCaMKII, Zif-268 and BDNF, respec-
tively. Quantitative results are shown in Figure 4,
Supplementary Figure 1 (densitometry) and Figure 5 (cell
counting, only for zif-268).
Figure 4 shows that pCaMKII levels in pooled hippocampal
data 3 h after injection were lower in the haloperidol and
vehicle groups, in comparison with naïve animals. Haloperidol-
treated animals showed lower levels than naïve and vehicle
animals 6 h after injection. Animals killed 12 h after injection
showed lower levels of pCaMKII in the haloperidol group, in
comparison with the vehicle group (statistics in Table 1). In the
analysis of separate hippocampal regions 3 h after injection, a
signiﬁcant difference was observed only in the CA3 region
(Supplementary Figure 1A, F=5.58, p=0.049, statistics in
Supplementary Table 2). At 6 h post-injection, a decrease of
pCaMKII levels was detected in the haloperidol group in CA1
(F=33.22; p=0.0003), CA3 (F=28.28; p=0.0003) and DG
(F=11.56; p=0.0027) (Supplementary Figure 1A; statistics in
Supplementary Table 3). At 12 h post-injection, pCaMKII levels
were lower in the haloperidol group in comparison with the
vehicle group in CA1 (F=9.23; p=0.0051), CA3 (F=14.24;
p=0.0003) and DG (F=11.12; p=0.0024; Supplementary
Figure 1A statistics in Supplementary Table 4).
Signiﬁcant differences in Zif-268 levels were observed only
at 6 h post-injection. The haloperidol group showed lower Zif-
268 levels than the vehicle and naïve groups (two-way ANOVA:
Time: F (2, 45)=0.14, p=0.86, Treatment: F (2, 45)=7.82,
po0.0012; Interaction: F (4, 45)=5.58, po0.0007; see
Table 1). Similar results were observed when we analyzed
the different hippocampal regions: at 6 h post injection,Light Dark
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Figure 2 Haloperidol modulates memory for novel objects in mice
the exploration time of unfamiliar/familiar objects. (A) Animals tra
for novel objects when injected with vehicle immediately after tra
during the dark phase (night) failed to show novel object preferenc
post-hoc test was applied for the comparisons. (B) Effect on prefer
ANOVA followed by Bonferroni post-hoc test were applied. Haloper
but this effect disappeared when animals were injected 6 h after tZif-268 staining was signiﬁcantly decreased in the haloperidol
group in CA1 (F=14.27; p=0.0009) and CA3 (F=9.92;
p=0.0054), in comparison with naïve and vehicle groups (Supp-
lementary Figure 1B; statistics in Supplementary Table 3).
The effect of haloperidol in BDNF levels was observed
only at 12 h post injection. Staining in the haloperidol group
was signiﬁcant lower than in the vehicle group (two-way
ANOVA: Time: F (2, 43)=0.22, p=0.80, Treatment: F (2, 43)
=5.18, po0.009; Interaction: F (4, 43)=0.91, p=0.91, sta-
tistics in Table 1). A non-signiﬁcant statistical trend was
observed in the DG at 12 h post-injection, with lower levels
in the haloperidol group than in animals injected with
vehicle (F=2.06, p=0.056) (Supplementary Figure 1C, sta-
tistics in Supplementary Table 4).3.3. VH and haloperidol inter-time comparisons
We then analyzed the data through separate comparisons
over time for the VH and haloperidol groups. For pCaMKII
levels, ANOVA revealed lower immunostaining in the VH 3 h
group, in comparison with the other groups (naive, 6 h and
12 h), in DG (F=8.346; p=0.0009), CA1 (compared only to
6 h and 12 groups; F=10.28; p=0.0002) and CA3 (compared
only to 6 h and 12 h groups; F=9.218; p=0.0004). No
differences were found for the VH inter-time comparisons
of Zif-268 and BDNF staining among naïve, 3 h, 6 h and 12 h
groups (Figure 4). For inter-time comparisons among groups
injected with haloperidol, there was decreased immunor-
eactivity for pCaMKII levels at 6 h compared in DG (F=
6.708; p=0.0026, comparison to naïve), and CA1 (F=16.34;
p=0.0001, comparison to naïve and haloperidol 12 h). In
CA3 there was decreased pCaMKII labeling in haloperidol
3 h and haloperidol 6 h in comparison to the naïve group.
(F=9.400; p=0.0004). For Zif-268 staining, ANOVA revealed
a decrease at 6 h when compared to all other time points, in
both CA1 (F=12.42; Po0.0001) and CA3 (F=9.672; p=
0.0004; Figure 4). For BDNF, ANOVA revealed no differences
in haloperidol inter-time comparisons (Figure 4).IAE 6h
0.0
0.5
1.0
1.5
2.0
2.5
Vehicle
Halo 
**
(N=7–8 animals per group) Preference ratio was calculated as
ined during the light phase (morning) showed clear preference
ining, but not when injected with haloperidol. Animals trained
e for either treatment. Two-way ANOVA followed by Bonferroni
ence ratio of haloperidol injected in the light phase. Two-way
idol impairs learning when injected immediately after training,
raining.*po0.05, **po0.01, ***po0.001.
Table 1 Statistical summary of the signiﬁcant results in the densitometry analysis for pCaMKII, Zif-268 and BDNF staining.
MANOVA comparisons of labeling measurements in the hippocampus were followed by Bonferroni post-hoc tests. Comparisons
were performed considering two independent variables: treatment and time of injection.
pCaMKII
Source of variation MANOVA
F P value DF
Interaction 7.87 0.0001 (4,54)
Treatment 42.88 0.0001 (2,54)
Time 1.67 0.19 (2,54)
Time Bonferroni
Groups Mean7SEM; N P value
3 h NVHalo 1.0870.05; N=7 Po0.001
0.8370.05; N=6
NVVH 1.0870.05; N=6 Po0.05
0.9270.04; N=5
6 h NVHalo 1.0570.05; N=7 Po0.001
0.7070.02; N=6
VHHalo 1.1770.01; N=6 Po0.001
0.7070.02; N=6
12 h NV halo 1.1470.01; N=7 Po0.01
0.8770.03; N=7
Zif-268
Source of variation MANOVA
F P value DF
Interaction 5.58 0.0007 (4,45)
Treatment 7.82 0.0012 (2,45)
Time 0.14 0.86 (2,45)
Time Bonferroni
Groups Mean7SEM; N P value
6 h NVHalo 1.1770.05; N=6 Po0.001
0.6570.08; N=6
VHHalo 1.0970.07; N=6 Po0.001
0.6570.08; N=6
BDNF
Source of variation MANOVA
F P value DF
Interaction 0.24 0.91 (4,43)
Treatment 5.18 0.009 (2,43)
Time 0.22 0.80 (2,43)
Time Bonferroni
Groups Mean7SEM; N P value
12 h VHHalo 1.1470.06; N=7 Po0.05
0.8970.04; N=7
A.S.C. França et al.4983.4. IHC quantiﬁcation of Zif-268 by cell counting
Most of the results obtained by cell counting (Figure 5) were in
accordance with the densitometry measurements. For the 3 h
post-injection time, we observed increased Zif-268 reactivityin the VH group in CA1 comparison to the naïve group
(F=5.323; p=0.066), and in CA3 when compared to naïve
and haloperidol groups (F=12.59; p=0.003). At 6 h post-
injection, we found a decrease in CA1 in the haloperidol
group, when compared to naïve and vehicle groups (F=24.97;
Figure 3 Haloperidol injection decreases the hippocampal levels of pCaMKII, Zif-268 and BDNF according to a temporal gradient.
The columns exemplify representative data of different groups. Arrows indicate hippocampal regions (DG, CA3, CA1) with signiﬁcant
labeling differences in the haloperidol group, in comparison with naive and vehicle groups (empty and ﬁlled arrows, respectively).
Non-exposed, not injected naive animals (NV), and animals injected with haloperidol (HALO) or vehicle (VH) immediately after
training were euthanized at 3 h, 6 h and 12 h post-exploration. The ﬁrst three rows represent frontal hippocampal sections at 40
labeled for pCaMKII (A), Zif-268 (B) or BDNF (C). The last row at 200 focuses on regions where signiﬁcant differences were
detected (D). Panels show differential labeling for pCaMKII (naïve and 3 h), Zif-268 labeling at 6 h (vehicle), and BDNF at 12 h
(vehicle). Please note that haloperidol decreased the hippocampal levels of pCaMKII at all time points. Decreased Zif-268 levels in
the haloperidol group were detected only after 6 h, while decreased BDNF levels occurred only after 12 h.
499Dopaminergic regulation of learning, sleep and plasticityPo0.0001). At 12 h post-injection, no signiﬁcant differences
were found among groups in CA1 and CA3. In VH inter-time
comparisons, we observed no differences among naïve, 3 h,
6 h and 12 h groups. Nevertheless, haloperidol-injected ani-
mals presented differential staining at these time points
(ANOVA F=7.689; p=0.004). In CA1, we observed a decrease
in Zif-268 at 6 h when compared to naïve (P40.01) haloper-
idol 3 h (Po0.01) and 12 h groups (Po0.05). At CA3 we
observed a similar reduction in animals injected with haloper-
idol at a 6 h time point (ANOVA F=9.181 and p=0.002), when
compared to 3 h (Po0.05) and 12 h groups (Po0.05), and a
reduction in naïve animals compared to the haloperidol 3 h
group (Po0.05).3.5. Haloperidol impairs memory recognition and
decreases REM sleep duration
To test the inﬂuence of haloperidol on speciﬁc sleep states,
we subjected animals to the object recognition task,
injected either haloperidol or vehicle, and performed sub-
sequent electrophysiological recordings across the sleep–
wake cycle. Two-Way ANOVA was used to compare exposed
animals (vehicle and haloperidol 0.3 mg/kg I.A.E.) to con-
trols (vehicle and haloperidol 0.3 mg/kg I.A.E.). Compar-
isons were independently made for the duration of each
state (WK, SWS, REM) versus the independent variables tre-
atment (haloperidol/vehicle) and task (exposure and con-
trol). For WK and SWS, the two-way ANOVA detected no
difference regarding treatment (F (1, 14)=1.76 p=0.21 for
WK; F (1, 14)=0.07 p=0.80 for SWS) or task (F (1, 14)=3.63
p=0.07 for WK; F (1, 14)=0.50 p=0.49 for SWS). For REM
sleep, however, signiﬁcant differences were detected for
both treatment (F (1, 14)=7.69 p=0.014) and task: (F (1,
14)=32.85 Po0.0001). Bonferroni post hoc tests pointed to
decreased REM sleep duration in both haloperidol andvehicle control groups, in comparison with corresponding
object-exposed groups (Figure 6A). We also detected a
signiﬁcant reduction of the preference ratio in
haloperidol-injected I.A.E. mice (Figure 6B).
Finally, to investigate the relationship between object
recognition and REM sleep duration, we calculated the
Spearman correlation between normalized preference ratio
and normalized REM sleep duration (Haloperidol or Vehicle
divided by [Haloperidol+Vehicle]). We found that lower
preference indexes in haloperidol-injected animals were
signiﬁcantly correlated with lower REM sleep durations, just
like the higher preference and higher REM sleep durations
veriﬁed in control animals were also correlated (Figure 6C;
Rho=0.56 p=0.0125).4. Discussion
In the present work we aimed at a better understanding of the
biological mechanisms that link sleep, memory formation and
dopamine receptor regulation. The behavioral and electro-
physiological data showed that haloperidol impairs novel
object recognition when injected immediately after training,
but has no effect when injected 6 h later. Haloperidol also
decreases total REM sleep duration for up to 4 h after training.
Importantly, for injections immediately after training, learning
and REM sleep duration showed strong positive correlation,
suggesting a possible common cause linking REM sleep reduc-
tion and learning deﬁcits. Mechanistic insight was sought thr-
ough an assessment of calcium-dependent plasticity factors.
We found that haloperidol injection immediately after training
decreased the hippocampal levels of these factors for several
hours after treatment, starting with pCaMKII at 3 h, Zif-268 at
6 h and then BDNF at 12 h. Our data point to the calcium-
dependent plasticity pathway as a candidate to mediate the
effects of haloperidol on both sleep and learning.
Figure 4 Densitometry quantiﬁcation of pCaMKII, Zif-268 and
BDNF staining at three distinct time points. The three graphs
represent pCaMKII, Zif-268 and BDNF staining measures at
different time points (3 h, 6 h and 12 h as indicated). Vehicle
and haloperidol were injected immediately after exploration.
Naïve animals did not receive any injection, nor were presented
to objects. Two-way ANOVAs and Bonferroni post-hoc tests were
performed for comparisons among these groups for each
molecule, considering time and treatment as independent
variables. *po0.05, ***po0.001 related to vehicle groups;
po0.05, po0.001 related to control groups.
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consolidation of memories has been previously reported in the
literature. While haloperidol impairs water maze learning
(Morice et al., 2007), dopamine D2 agonists decr-
ease memory consolidation in fear conditioning (Nader and
LeDoux, 1999), and impair the extinction of conditioned fear
memory (Ponnusamy et al., 2005). Both antagonists and
agonists of D1 receptors reduce memory consolidation in a
fear-conditioning task (Rossato et al., 2009). Haloperidol works
as an inverse agonist of D2 receptors, disinhibiting adenylyl
cyclase activity and therefore leading to elevated cyclic AMP
levels (Konradi and Heckers, 1995). Zif-268 and BDNF are
thought to be directly inﬂuenced by prior activation of
pCaMKII-mediated signaling pathways (Hasbi et al., 2009). It
is therefore expected that the levels of cAMP-inﬂuenced
targets such as pCaMKII (Blitzer et al., 1998), Zif-268 (Kang
et al., 2007) and BDNF (Ji et al., 2005; Bekinschtein et al.,2007) are decreased after haloperidol treatment. The putative
mechanism to explain the dopaminergic inﬂuence on memory-
related plasticity factors is the regulation of non-NMDA
glutamatergic receptor activation by D2 dopamine receptor
(Hakansson et al., 2006). Since these factors show experience-
dependent up-regulation during REM sleep (Ribeiro et al.,
1999, 2007; Ulloor and Datta, 2005), the decrease in REM sleep
promoted by haloperidol is likely to contribute further to the
decrease in the levels of plasticity factors.
One important aspect to consider is the possible motor
effect of haloperidol. At high doses, haloperidol impairs
motility for several hours after injection. However, no
motility differences were detected when total travelled
distance was assessed one day after drug injection (data not
shown). Furthermore, haloperidol-injected animals injected
immediately after training exhibited no object preference
24 h later, indicating that these learning deﬁcits are not
related to a possible decrease in motor activity during expl-
oration of the novel objects, but rather reﬂect an impair-
ment in post-exploration memory consolidation.
A time course analysis of the molecular data indicates
that haloperidol impairs calcium signaling through a broad
cascade of events distributed over time (Figure 4). At 3 h
post-exploration, haloperidol decreased pCaMKII levels in
the CA3 ﬁeld; at 6 h and 12 h post-exploration, the decrease
in pCaMKII levels occurred in all hippocampal regions (Sup-
plementary Figure 1, left panels). Zif-268 levels were sign-
iﬁcantly reduced by haloperidol 6 h after training (Supp-
lementary Figure 1, middle panels), and BDNF levels were
decreased by haloperidol 12 h after training in the DG ﬁeld
(Supplementary Figure 1, right panels).
Although several studies have reported increased pCaMKII
activity after task training or LTP induction, the exact time
window for the activation of this kinase after stimulus remains
controversial. A study using in vitro LTP recordings found a
signiﬁcant increase in pCaMKII in the CA1 ﬁeld 30 min after
tetanic stimulation (Ouyang et al., 1997), whereas another
study revealed that CaMKII remained in a speciﬁc, but enh-
anced phosphorylated state during the induction, and through-
out early- and late-LTP, maintaining high levels for 8 h (Ahmed
and Frey, 2005). The use of different tetanization paradigms in
those studies possibly resulted in large calcium inﬂux changes,
affecting other signaling mechanisms in a dose-dependent
manner. Additionally, in vitro CaMKII phosphorylation in the
hippocampus was increased 30 min after inhibitory avoidance,
but not after 120 min (Cammarota et al., 1998). CaMKII plays a
role in plasticity-related synaptic tagging, a mechanism whe-
reby suitable synapses are sorted for subsequent strengthening
(Hernandez and Abel, 2011).
Zif-268 levels were lower in animals treated with haloper-
idol at 6 h (Figures 4, 5 and Supplementary 1). Since Zif-268
levels in the hippocampus are increased 1–2 h after a novel
stimulus (Barbosa et al., 2013), we believe that a 6 h increase
in vehicle-injected animals could be related to a second wave
of Zif-268 transcription and translation. This re-induction is
probably related to the occurrence of REM sleep in vehicle-
injected animals, but not in haloperidol-injected animals,
during the 4 h interval following object exposure.
Our results corroborate the notion of a late phase of BDNF
synthesis in the rat hippocampus 12 h after training, related
to the long-term persistence of memories (Bekinschtein
et al., 2007, 2014). A signiﬁcant decrease of BDNF levels
Figure 5 Cell counting quantiﬁcation of Zif-268 staining at three distinct time points. The ﬁrst three plots from left to right
illustrate Zif-268 individual cell staining of naïve (NV), vehicle (VH) and haloperidol (Halo) groups at different time points, set at 3 h
(A), 6 h (B) and 12 h (C) after injection, using Bonferroni-corrected ANOVAs followed by Bonferroni post-hoc tests. The two last plots
on the right illustrate inter-time ANOVA followed by Bonferroni post-hoc comparisons in vehicle groups (D) and Halo groups
(E) performed to evaluate the time course of Zif-268 protein levels in CA1 and CA3. Bars in black and white represent CA3 and CA1,
respectively. In A, B, C, *po0.05, **po0.01, ***po0.001 related to vehicle groups; po0.05, po0.01, po0.001 related to control
groups. In D and E, the differences are indicated by linked lines.
501Dopaminergic regulation of learning, sleep and plasticityin the hippocampus of animals treated with haloperidol was
detected in the pooled data (Figure 4). Injections of anti-
BDNF antibodies into the DG demonstrated BDNF's essential
role in the spontaneous location recognition task, impairing
task execution when animals had to disambiguate two
similar locations within an open ﬁeld, but not when these
locations were made less similar (Bekinschtein et al., 2014).
Injection of recombinant BDNF into the DG enhanced patt-
ern separation. Furthermore, exposure of the animals to
either similar or dissimilar objects led to a 4-fold increase in
BDNF levels in the DG when rats explored two similar loc-
ations, but not when dissimilar locations were explored
(Katche et al., 2010; Bekinschtein et al., 2014).
Various studies have described the relation of BDNF with
other molecules involved in synaptic and cellular plasticity.
Activity-dependent BDNF upregulation may depend on
interaction with the NMDA receptor, which in turn interacts
with CaMKII (Sanhueza et al., 2011). The blockade of NMDA
and pCaMKII fully abolishes exercise-induced increases in
synapsin I and TrkB mRNA levels, promoting a decrease
of CREB and BDNF mRNA levels (Vaynman et al., 2003).
Complementarily, BDNF blockade 12 h after a behavioraltask prevents a late increase in c-Fos and Zif-268 proteins,
24 h after the initial stimulus (Bekinschtein et al., 2007).
The cyclic reactivation of plasticity-related proteins during
the post-training time may be essential to consolidate certain
kinds of memory Ribeiro and Nicolelis 2004; Hernandez and
Abel, 2011). For instance, the long-term persistence of some
memories depends on the circadian reactivation of the cAMP/
MAPK/CREB transcriptional pathway in the hippocampus
(Eckel-Mahan et al., 2008). This pathway can be modulated
by sleep deprivation, circadian rhythms, and neurotransmitter
systems involved in sleep–wake regulation (Hernandez and
Abel, 2011). The dopaminergic regulation of calcium-
dependent signaling pathways is a likely candidate mechanism
to causally connect sleep deﬁcits and learning impairment.Conﬂicts of interest
We declare no conﬂicts of interest with regard to the study
“D2 dopamine receptor regulation of learning, sleep and
plasticity”.
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Figure 6 Haloperidol reduces REM sleep and proportionally impairs novelty preference. (A) Duration (minutes over a 4 h interval)
of WK, SWS and REM sleep in control versus exposed animals, injected with either vehicle or haloperidol immediately after
exploration. Haloperidol treatment or novelty exposure had no effect on the duration of WK or SWS (two-way ANOVA). In contrast,
REM sleep was signiﬁcantly affected by both factors, with increased REM sleep duration after novelty exposure, and decreased REM
duration after haloperidol. (B) Animals injected with haloperidol showed decreased novelty preference ratio in comparison with
vehicle-injected controls group. (C) Normalized REM sleep duration and normalized preference ratio (Halo or Vehicle/Halo+Vehicle)
are positively correlated (Spearman's regression R=0.56, p=0.0127). *po0.05 and ***po0.001.
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